Skip to main content
. 2020 Mar 31;18:147. doi: 10.1186/s12967-020-02305-z

Table 1.

Details of transplanted groups, and experimental endpoints

Donor Recipient Treatment Group purpose Assessments (d)
C57BL/6 C57BL/6 Saline Saline-treated syngraft control 6, 8, 10
BALB/c C57BL/6 Saline Saline-treated allograft control 6, 8, 10

Sample size (n) = 6–12 transplants/time points/experiment